HealthDay: Information For Healthier Living
WEBExplore HealthDay for comprehensive health topics, latest medical news, and wellness tips. Trusted for accuracy and expertise.
FDA Expands Use of Breast Cancer Drug Kisqali
WEB1 day ago · Sep 18, 2024, 11:05 am. WEDNESDAY, Sept. 18, 2024 (HealthDay News) -- Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment, drug maker Novartis announced Tuesday. “The FDA approval of Kisqali for this ...
Post-Op Keytruda Treatment Boosts Bladder Cancer Outcomes
WEB1 day ago · A new trial finds that post-op use of the immunotherapy drug Keytruda can double the time these patients spend cancer-free. Similar findings had already been seen with another immunotherapy drug, Opdivo. WEDNESDAY, Sept. 18, 2024 (HealthDay News) -- When given after organ-removal surgery, Keytruda brings patients battling advanced bladder ...
Feeling Content Helps Shield You From Heart Attack, Stroke
WEB1 day ago · A 44% lower risk of clogged arteries. A 45% lower risk of stroke. A 51% lower risk of heart failure. A 56% lower risk of heart attack. Further analysis suggested that people who feel more content tend to adopt healthier lifestyles and suffer less inflammation, researchers said. “These results underscore the profound impact that emotional and ...
Outcomes Generally Good for Face Transplant Recipients
WEB1 day ago · WEDNESDAY, Sept. 18, 2024 (HealthDay News) -- There have been 50 face transplants performed in 11 countries since the surgery was pioneered back in 2005, and long-term outcomes have been favorable, a new review finds. In total, 85% of people receiving these complex surgeries survived five years and 74% were still alive a decade after transplant ...
Dual Treatment Doubles Survival With For Folks Advanced Kidney …
WEB2 days ago · Key Takeaways. Adding bevacizumab to pazopanib more than doubled survival for people with advanced kidney cancer, compared to pazopanib alone. Bevacizumab helps thwart cancer cell resistance to pazopanib, researchers explained. The study was small, so larger trials are needed. TUESDAY, Sept. 17, 2024 (HealthDay News) -- A small clinical trial ...
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, …
WEBAug 30, 2024 · A slew of new studies suggest that semglutide (Ozempic/Wegovy) has benefits for health that extend beyond weight loss. Subset analyses of prior trials find the drug can curb deaths from all causes, ease COVID-19 severity and treat heart failure. These benefits weren't always the result of weight loss, …
FDA Could OK Fall COVID Shots as Early as This Week - HealthDay
WEBTUESDAY, Aug. 20, 2024 (HealthDay News) -- Updated shots you could use this fall to shield against COVID-19 infection may receive approval this week. Two sources familiar with the issue told CNN that updated mRNA vaccines from Moderna and Pfizer that target a variant of the virus called KP.2 could be greenlit as early as this week.
Study Shows How Fruits, Veggies Lower Blood Pressure, Heart Risks
WEBTUESDAY, Aug. 6, 2024 (HealthDay News) -- Eating more fruits and veggies can lower blood pressure and improve heart health by reducing acid levels in the body, a new clinical trial finds.. People who added two to four cups of fruits and vegetables to their daily diet wound up with lower blood pressure and reduced heart disease risk, as well as improved kidney health, trial results published ...
HealthDay News - The Latest Fact Based Health Information
WEBStay informed with HealthDay Consumer News, offering the latest health updates based on scientific medical discoveries
Skip to content